Schedule 13D ownership disclosure

Inhibrx Biosciences Inc

Common Stock, par value $0.0001 per share · CUSIP: 45720N103

Event date: 2024-09-12

Filing-level shares
925,413.00
Percent of class
6.4%
  • Mark LappeReported CIK 0001366074

    Shares: 925,413.00 · Class: 6.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002007919-25-000012
Form type
SCHEDULE 13D/A
Filer
Inhibrx Biosciences, Inc.
CIK
CIK 2007919
Filed
Feb 26, 2025
Reporting period
Sep 12, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub